HighTower Advisors
ROIV icon

HighTower Advisors’s Roivant Sciences ROIV Stock Holding History

HighTower Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Sell
28,287
-5,377
-16% -$159K ﹤0.01% 2239
2026
Q1 		$932K Buy
33,664
+4,804
+17% +$123K ﹤0.01% 2232
2025
Q4 		$626K Buy
28,860
+3,673
+15% +$72.5K ﹤0.01% 2451
2025
Q3 		$381K Buy
25,187
+7,044
+39% +$87.2K ﹤0.01% 2836
2025
Q2 		$204K Buy
18,143
+4,211
+30% +$45.6K ﹤0.01% 3263
2025
Q1 		$141K Buy
13,932
+3,719
+36% +$40.2K ﹤0.01% 3283
2024
Q4 		$121K Buy
+10,213
New +$121K ﹤0.01% 3337
2023
Q1 		– Sell
-18,200
Closed -$146K – 3632
2022
Q4 		$146K Buy
+18,200
New +$101K ﹤0.01% 2865

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HighTower Advisors's ROIV Position: Q2 2026 in Review

HighTower Advisors reduced its Roivant Sciences (ROIV) stake by 16% in Q2 2026, selling an estimated $159K and leaving 28,287 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

HighTower Advisors first reported a position in ROIV in Q4 2022 and has held it in 8 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • HighTower Advisors held 28,287 shares of Roivant Sciences worth $1M as of Q2 2026.
  • HighTower Advisors sold 5,377 Roivant Sciences shares in Q2 2026, an estimated $159K.
  • Roivant Sciences made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2239 holding.
  • HighTower Advisors first reported a position in Roivant Sciences in Q4 2022 and has held it in 8 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.